PL BioScience GmbH | WebDisclosure

Basculer en Français

10674	Companies
227652	Keywords
156044	Articles
120590	Press releases

Home
Companies
PL BioScience GmbH

PRESS RELEASE

published on 06/11/2025 at 10:00, 1 year ago

PL BioScience Strengthens Management Team with Appointment of Oliver Dick as Chief Technology Officer
PL BioScience strengthens management team with appointment of Oliver Dick as Chief Technology Officer. Oliver Dick brings 30 years of expertise in life science, diagnostic, and biopharma operations

Chief Technology Officer Biopharmaceutical Life Science PL BioScience Oliver Dick
BRIEF

published on 05/19/2025 at 15:05, 1 year 1 month ago

PL BioScience et DewCell s'associent pour développer des plaquettes humaines artificielles

Plaquettes Artificielles Milieux De Culture Cellulaire Développement HPL Solutions Sans Animaux Collaboration Biotechnologique
BRIEF

published on 05/19/2025 at 15:05, 1 year 1 month ago

PL BioScience and DewCell Partner on Artificial Human Platelets

Biotech Collaboration Artificial Platelets Cell Culture Media HPL Development Animal-free Solutions
PRESS RELEASE

published on 05/19/2025 at 15:00, 1 year 1 month ago

PL BioScience and DewCell sign LOI to Jointly Develop Artificial Human Platelets for Scalable, Animal-Free Cell Culture Media
PL BioScience and DewCell sign LOI to jointly develop artificial human platelets for scalable, animal-free cell culture media. The collaboration aims to meet demand driven by regulatory trends in cell- and gene therapy development

PL BioScience Cell Culture Media DewCell Artificial Human Platelets Regulatory Trends
BRIEF

published on 05/08/2025 at 14:05, 1 year 1 month ago

PL BioScience dévoile le premier lysat plaquettaire humain artificiel au monde

Médecine Régénérative Produits Biopharmaceutiques Culture Cellulaire PL BioScience HPL Artificiel
BRIEF

published on 05/08/2025 at 14:05, 1 year 1 month ago

PL BioScience Unveils World's First Artificial Human Platelet Lysate

Regenerative Medicine Biopharmaceuticals Cell Culture PL BioScience Artificial HPL
PRESS RELEASE

published on 05/08/2025 at 14:00, 1 year 1 month ago

PL BioScience Raises the Bar in Cell Culture Technology with First Artificial Human Platelet Lysate Worldwide
PL BioScience GmbH introduces first artificial Human Platelet Lysate (HPL) worldwide, revolutionizing cell culture technology for biopharmaceutical applications

Biopharmaceutical Human Platelet Lysate PL BioScience Artificial Cell Culture Technology
BRIEF

published on 04/30/2025 at 12:05, 1 year 2 months ago

PL BioScience Unveils Unique Gamma-irradiated Human Platelet Lysate

Regenerative Medicine Cell Therapy Human Platelet Lysate Gamma-Irradiation Xeno-Free Supplement
BRIEF

published on 04/30/2025 at 12:05, 1 year 2 months ago

PL BioScience dévoile un lysat plaquettaire humain unique irradié aux rayons gamma

Médecine Régénérative Thérapie Cellulaire Lysat Plaquettaire Humain Irradiation Gamma Supplément Sans Xénobiotiques
PRESS RELEASE

published on 04/30/2025 at 12:00, 1 year 2 months ago

PL BioScience Launches World’s Only Patented Gamma-irradiated Human Platelet Lysate
PL BioScience launches ELAREM™ Ultimate-FD PLUS, the only gamma-irradiated, GMP-grade Human Platelet Lysate in Europe. The product offers a safer, sustainable, virus-inactivated, and animal-free alternative for cell manufacturing applications

GMP-grade Human Platelet Lysate PL BioScience ELAREM Ultimate-FD PLUS Gamma-irradiated

Accesswire

Published on 07/02/2026 at 08:00, 49 minutes ago

Mid-Year Operational and Corporate Update
Published on 07/01/2026 at 17:00, 15 hours 49 minutes ago

Notification of Relevant Change to Significant Shareholder
Published on 07/01/2026 at 14:30, 18 hours 19 minutes ago

AIAI Holdings' MediGuide Launches Digital Platform
Published on 07/01/2026 at 13:30, 19 hours 19 minutes ago

Sidney Resources Corporation Appoints Former Idaho Governor C.L. "Butch" Otter as Chairman of the Board
Published on 07/01/2026 at 13:00, 19 hours 49 minutes ago

Fox River Issues Shares Pursuant to Exploration Agreement in Connection with Impending Arrangement

View all ACCESSWIRE

EQS Group

Published on 07/02/2026 at 08:30, 19 minutes ago

Suspension - TREATT PLC
Published on 07/02/2026 at 08:11, 37 minutes ago

Genel Energy PLC: Potential tap issue of existing bond
Published on 07/02/2026 at 08:10, 38 minutes ago

NNS confirms continued support for Rembrandt II
Published on 07/02/2026 at 08:05, 43 minutes ago

einwert Becomes Part of Newmark's Valuation & Advisory Business in Germany
Published on 07/02/2026 at 08:00, 49 minutes ago

Nebius celebrates healthcare and life sciences innovators at expanded AI Discovery Awards

Les Echos

Published on 07/01/2026 at 19:40, 13 hours 8 minutes ago

Initiation de couverture du titre Solocal par Portzamparc
Published on 07/01/2026 at 18:40, 14 hours 9 minutes ago

LNA SANTE : Acquisition de 5 EHPAD
Published on 07/01/2026 at 18:26, 14 hours 23 minutes ago

Modula renews its confidence in AMA with a four-year agreement integrating XpertEye’s new AI-powered features
Published on 07/01/2026 at 18:26, 14 hours 23 minutes ago

Modula renouvelle sa confiance à AMA avec un contrat de quatre ans intégrant les nouvelles fonctionnalités IA d’XpertEye
Published on 07/01/2026 at 18:01, 14 hours 48 minutes ago

Covivio Hotels - Informations relatives au nombre total de droits de vote et d’actions composant le capital social

View all LES ECHOS COMFI WIRE